Acucela
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1301 2nd Ave Ste 1900, Seattle, Washingt...Phone Number
(206) 805-8300Website
www.kubotavision.comRevenue
$26.1 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Acucela
Kubota Vision Inc. is dedicated to translating innovation into a diverse range of drugs and devices aimed at preserving and restoring vision for millions of individuals globally. As a part of Kubota Pharmaceutical, the company is focused on developing solutions aimed at curing blindness. Their mission revolves around creating a world without blindness. The company targets a wide audience, including those affected by vision impairment.Explore more
Acucela Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Acucela your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Acucela is spiking on competitors!
Check if Acucela has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Acucela
Funding: Get notified immidiatlly once Acucela has new funding data
Acucela, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Acucela recently announced quarterly report
Product Launch: Get notified when Acucela launches new products
Website visits: Recent activity has been detected on your website
Click to see if Acucela had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Acucela
Find more new buyers
Compare Similar Companies to Acucela
Compare insights from companies similar to Acucela, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Acucela is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Acucela is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Acucela.
Acucela Tech Stack
A closer look at the technologies used by Acucela
Most Recent Scoops
Left Company
Executive Move
John Gebhart, Chief Financial Officer, has left the organization.
Executive Move
Executive Moves, Board of Directors
Partnership
Acucela has entered into an agreement, along with subsidiary Kubota Pharmaceutical Holdings, with the Translational Research Institute for Space Health (TRISH) to develop an OCT *1 device to support Deep Space missions conducted by NASA.
Partnership, Engineering, Research & Development
Partnership
Acucela News & Media
Kubota Vision Announces Vendor Agreement with IQVIA for eyeMO
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the execution of a vendor agreement between Kubota Vision and IQVIA Services Japan G.K. (“IQVIA”) for eyeMO (Patient Based Ophthalmology Suite), a portable, low-cost, home-based, remote and in-office ophthalmic OCT*1 device for monitoring of retinal diseases. ThisKubota Vision Announces Collaborative Research Agreement with China Medical University Hsinchu Hospital
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision” or the “Company”), a clinical-stage specialty ophthalmology company and a wholly owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the execution of a collaborative research agreement between Kubota Vision and China Medical University Hsinchu Hospital, Department of Ophthalmology, for a study using Kubota Glass in Taiwan, led by Dr. Ying-Shan Chen. The prospective study will evaluate the effectKubota Pharmaceutical Group Launches Its Unique Kubota Glass Technology Aiming to Revolutionize Myopia Management
Tokyo, Japan--(Newsfile Corp. - February 24, 2023) - Kubota Pharmaceutical Holdings (JPX: 4596) and its subsidiary Kubota Vision Inc. (Kubota Pharmaceutical Group), an ophthalmic medical solutions company headquartered in Tokyo, launches its unique Kubota Glass technology, aiming to revolutionize myopia management. Based on the technology, the company introduced a wearable device called Kubota Glass illuminated spectacles. These glasses are designed to correct refractive errors and provide speciKubota Vision Announces Positive Post Hoc Analysis from Phase 3 Clinical Trial of Emixustat in Patients with Stargardt Disease
SEATTLE--(BUSINESS WIRE)--Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today positive results from a post hoc analysis of the phase 3 clinical trial of the investigational visual cycle modulator emixustat hydrochloride (emixustat) in patients with Stargardt Disease. The primary objective of this study was to determine if emixustat reduces the rate of macular atrophy pr
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Acucela
Sign Up For FreeTo access detailed company insights
Kubota Vision Inc. is dedicated to translating innovation into a diverse range of drugs and devices aimed at preserving and restoring vision for millions of individuals globally. As a part of Kubota Pharmaceutical, the company is focused on developing solutions aimed at curing blindness. Their mission revolves around creating a world without blindn... Read More
